Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Immunome Inc
NASDAQ:IMNM
Immunome Inc
NASDAQ:IMNM
Price:
18.76
USD
-7.63%
Market Closed
Market Cap:
$2.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Immunome Inc
NASDAQ:IMNM
|
US |
|
H
|
HAL Trust
OTC:HALFF
|
NL |
|
Olam Group Ltd
SGX:VC2
|
SG |
|
F
|
Fine Digital Inc
KOSDAQ:038950
|
KR |
|
W
|
Westinghouse Air Brake Technologies Corp
F:WB2
|
US |
Wall St Price Targets
IMNM Price Forecast
Based on 17 analysts
Based on 17 analysts
+90% Upside
from
$18.76
today
Immunome Inc (IMNM)’s 12-month stock price forecast through November 2027 has a consensus target of $35.7, implying 90% upside. The forecast is based on price targets from 17 Wall Street analysts.
IMNM Analyst Rating
Based on 17 analysts
Based on 17 analysts
Analysts rate IMNM Strong buy, with 16 of 17 recommending Buy or Strong buy.
Immunome Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IMNM's stock price target?
Price Target
35.7
USD
35.7
USD
According to Wall Street analysts, the average 1-year price target for IMNM is 35.7 USD with a low forecast of 18.47 USD and a high forecast of 42 USD.
What is the Revenue forecast for Immunome Inc?
Projected CAGR
93%
93%
The compound annual growth rate for Revenue over the next 8 years is 93%.
